RPRX NASDAQ
Royalty Pharma plc
1W: -1.8%
1M: -9.4%
3M: +0.4%
YTD: +47.9%
1Y: +58.2%
3Y: +127.9%
5Y: +70.8%
$57.16
-0.47 (-0.82%)
Weekly Expected Move ±3.2%
$53
$55
$57
$59
$61
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$25.3B
52W Range35.23-64.38
Volume2,226,091
Avg Volume3,333,992
Beta0.43
Dividend$0.93
Analyst Ratings
Company Info
CEOPablo Legorreta
Employees100
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2020-06-16
Websiteroyaltypharma.com
110 East 59th Street
New York, NY 10022
US
New York, NY 10022
US
212 883 0200
About Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Latest News
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Royalty Pharma (NASDAQ:RPRX) Stock: Insider Christopher Hite Sells 100,000 Shares
Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?
Andra AP fonden Lowers Stock Holdings in Royalty Pharma PLC $RPRX
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bassler Bonnie L | A-Award | 642 | $58.41 | 2026-09-30 |
| Urist Marshall | S-Sale | 4,126 | $57.88 | 2026-09-28 |
| Hite Christopher | S-Sale | 96,073 | $58.51 | 2026-09-22 |
| Hite Christopher | S-Sale | 3,927 | $58.93 | 2026-09-22 |
| Hite Christopher | G-Gift | 16,800 | — | 2026-08-19 |